D. Egg Et Al. , "Therapeutic options for CTLA-4 insufficiency.," The Journal of allergy and clinical immunology , vol.149, pp.736-746, 2022
Egg, D. Et Al. 2022. Therapeutic options for CTLA-4 insufficiency.. The Journal of allergy and clinical immunology , vol.149 , 736-746.
Egg, D., Rump, I. C., Mitsuiki, N., Rojas-Restrepo, J., Maccari, M., Schwab, C., ... Gabrysch, A.(2022). Therapeutic options for CTLA-4 insufficiency.. The Journal of allergy and clinical immunology , vol.149, 736-746.
Egg, David Et Al. "Therapeutic options for CTLA-4 insufficiency.," The Journal of allergy and clinical immunology , vol.149, 736-746, 2022
Egg, David Et Al. "Therapeutic options for CTLA-4 insufficiency.." The Journal of allergy and clinical immunology , vol.149, pp.736-746, 2022
Egg, D. Et Al. (2022) . "Therapeutic options for CTLA-4 insufficiency.." The Journal of allergy and clinical immunology , vol.149, pp.736-746.
@article{article, author={David Egg Et Al. }, title={Therapeutic options for CTLA-4 insufficiency.}, journal={The Journal of allergy and clinical immunology}, year=2022, pages={736-746} }